GPI is a nonprofit organization recognized as a leading promoter and defender of stem cell research and other cutting-edge medical research targeting cures. Since GPI's inception in 2003, its mission has been to establish a positive policy, regulatory and societal framework to enable research to flourish, under the highest ethical and medical standards. We seek to accelerate the discovery and development of lifesaving cures and therapies to alleviate human suffering due to chronic and terminal afflictions.
Diseases such as ALS, Cancer, Diabetes, Heart Disease, Multiple sclerosis (MS), Parkinson's Disease, and Spinal Cord Injury are affecting millions of people around the world. These people need life-saving cures and therapies now. Stem cell resarch & regenerative medicine offers the potential to cure these diseases, end suffering, create economic growth and reduce skyrocketing healthcare costs around the world driven by the treatment of these diseases and their complications.
The World Stem Cell Summit, produced by the Genetics Policy Institute (GPI), is the largest interdisciplinary, networking meeting of stem cell stakeholders, uniting the diverse regenerative medicine community. With the overarching purpose of fostering biomedical research, funding and investments targeting cures, the Summit is the single conference charting the future of this burgeoning field.
The program provides the research, industry, economic and societal context for understanding how all of the pieces of the stem cell puzzle fit together. The agenda features more than 150 speakers and 50 hours of in-depth presentations. Supported by 200 sponsors, exhibitors, endorsing organizations and media partners, the Summit is a three-day showcase of innovation, insight and inspiration.
The Stem Cell Action Coalition serves as an engine uniting the pro-cures community. We demand that both our elected and appointed officials in all branches and levels of government, establish embryonic stem cell research as a national public health priority.
These officials need to enact and uphold laws that protect funding for scientifically meritorious and ethically responsible research that will foster the emergence of cures sooner, rather than later.
Embryonic stem cell research has been called the most promising medical discovery of our time, and it remains the “gold standard” for stem cell scientists.
More than160 pages of previously unpublished insight into the forefront of regenerative medicine
The editors of the 2013 World Stem Cell Report invited experts to share their views on regenerative medicine strategies in the regions of North and South America, Europe and the Asia Pacific region, where stem cell research is on the forefront the biomedical research and commercialization agenda.
The report serves as a reference and guide to this diverse universe of organizations and networks that influence the success of our field.
Five honorees have been selected for the 2014 Stem Cell Action Awards. For 10 years, the Genetics Policy Institute (GPI) has honored the stem cell community's top innovators, leaders, and champions. Today's announcement in Texas by GPI Executive Director Bernard Siegel to leaders and supporters of San Antonio's biomedical sector renews San Antonio's commitment to the 2014 World Stem Cell Summit at the Marriott Rivercenter, San Antonio, Texas, December 3-5. Each year the honorees are announced in advance of the Summit, then presented at a gala dinner on Wednesday, December 3 during the World Stem Cell Summit.
This year's Stem Cell Action Award Honorees are a passionate group of innovative scientists, philanthropists and advocates, seeking an end to human suffering by charting the future of this burgeoning field. Previous Stem Cell Action awardees have included Maryland Governor Martin O'Malley, Michael J. Fox, Brooke Ellison, Robert Klein, Sherry Lansing, Susan Solomon of The New York Stem Cell Foundation, National Association of Biology Teachers, Juvenile Diabetes Research Foundation (JDRF), and philanthropists like A. Alfred Taubman and T. Denny Sanford.
- GPI Announces Launch of First "RegMed Capital Conference" (RMCC) as Co-Located Meeting at the World Stem Cell Summit, San Antonio, Dec. 3-5, 2014
October 2, 2014
- GPI's "Stem Cell Action Award" Honorees Announced
September 18, 2014
- Regenerative Medicine Foundation (RMF) is New Organizer of 2014 World Stem Cell Summit #WSCS14 in San Antonio, TX
September 10, 2014, 2014
Bernard Siegel's TedX talk "Stem Cells and the Transformative Power of Hope"
Bernard Siegel, a leader of the global stem cell advocacy movement and founder of the World Stem Cell Summit, describes how grassroots activists have contributed to the advancement of stem cell research, one of the greatest scientific breakthroughs of our time.
World Stem Cell Summit 2013
The 2013 World Stem Cell Summit took place in San Diego, California on December 4-6, 2013 at the Manchester Grand Hyatt. The Summit featured a record 200 expert speakers leading 67 sessions and panels and 37 "Conversation with Experts" roundtable discussions. Twelve hundred WSCS13 attendees represented more than 40 countries.
- Stem Cell Meeting on the Mesa
La Jolla, California
- World Stem Cell Summit
San Antonio, Texas